Paradoxical Hypotension after Volume Expansion with Plasma Protein Fraction
- 13 July 1978
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 299 (2) , 97-98
- https://doi.org/10.1056/nejm197807132990211
Abstract
The enormous growth of knowledge of the kallikrein-kinin system has resulted from advances in the detailed protein chemistry of these proteolytic enzymes, cofactors and substrates. Equally important in the development of this understanding have been careful investigation of the three congenital disorders of the system (deficiencies of Hageman factor, prekallikrein and high-molecular-weight kininogen) and delineation of the role of the kinins in a wide variety of diseases. The formation of bradykinin is initiated in plasma by conversion of Hageman factor (molecular weight of 85,000) from its precursor form to an activated molecule (factor XIIa) that triggers the intrinsic coagulation cascade. . . .Keywords
This publication has 8 references indexed in Scilit:
- Plasma Kallikrein Activation and Inhibition during Typhoid FeverJournal of Clinical Investigation, 1978
- Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.Journal of Clinical Investigation, 1977
- Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.Journal of Clinical Investigation, 1977
- Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.Proceedings of the National Academy of Sciences, 1976
- A Bradykinin‐Like Substance in Heat‐Treated Human Plasma Protein SolutionTransfusion, 1974
- ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASESThe Journal of Experimental Medicine, 1973
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1971
- Further Experience with a Concentrate Containing Human Antihaemophilic Factor*British Journal of Haematology, 1963